The differential expression of VISTA may be related to the difference in immunogenicity among different types of cancer, as ovarian carcinoma is a highly immunogenic tumor characterized by the expression of this immune-negative checkpoint [21, 22]. This evidence concerns the gene VSIR and ovarian carcinoma.